Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards

Aims Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of clinical pharmacology Vol. 90; no. 5; pp. 1231 - 1239
Main Authors De Vincentis, Antonio, Soraci, Luca, Arena, Elena, Sciacqua, Angela, Armentaro, Giuseppe, Aucella, Francesco, Corsonello, Andrea, Aucella, Filippo, Antonelli Incalzi, Raffaele
Format Journal Article
LanguageEnglish
Published England 01.05.2024
Subjects
Online AccessGet full text
ISSN0306-5251
1365-2125
1365-2125
DOI10.1111/bcp.16010

Cover

Loading…
Abstract Aims Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards. Methods We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug–drug interactions (DDIs). Results At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin‐K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage—17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00–1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02–1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91–0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19–3.13 for missed prescription). Conclusions This study showed a suboptimal DOAC prescriptive practice in older in‐patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real‐life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.
AbstractList Aims Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards. Methods We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug–drug interactions (DDIs). Results At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin‐K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage—17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00–1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02–1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91–0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19–3.13 for missed prescription). Conclusions This study showed a suboptimal DOAC prescriptive practice in older in‐patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real‐life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards. We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs). At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription). This study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.AIMSKnowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs).METHODSWe analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs).At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription).RESULTSAt hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription).This study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.CONCLUSIONSThis study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.
Author Arena, Elena
Aucella, Filippo
Antonelli Incalzi, Raffaele
Armentaro, Giuseppe
De Vincentis, Antonio
Sciacqua, Angela
Aucella, Francesco
Corsonello, Andrea
Soraci, Luca
Author_xml – sequence: 1
  givenname: Antonio
  orcidid: 0000-0003-0220-0500
  surname: De Vincentis
  fullname: De Vincentis, Antonio
  email: a.devincentis@policlinicocampus.it
  organization: Università Campus Bio‐Medico di Roma
– sequence: 2
  givenname: Luca
  surname: Soraci
  fullname: Soraci, Luca
  organization: IRCCS INRCA
– sequence: 3
  givenname: Elena
  surname: Arena
  fullname: Arena, Elena
  organization: Università Campus Bio‐Medico di Roma
– sequence: 4
  givenname: Angela
  surname: Sciacqua
  fullname: Sciacqua, Angela
  organization: “Magna Graecia” University of Catanzaro
– sequence: 5
  givenname: Giuseppe
  surname: Armentaro
  fullname: Armentaro, Giuseppe
  organization: “Magna Graecia” University of Catanzaro
– sequence: 6
  givenname: Francesco
  surname: Aucella
  fullname: Aucella, Francesco
  organization: IRCCS “Casa Sollievo della Sofferenza”
– sequence: 7
  givenname: Andrea
  surname: Corsonello
  fullname: Corsonello, Andrea
  organization: IRCCS INRCA
– sequence: 8
  givenname: Filippo
  surname: Aucella
  fullname: Aucella, Filippo
  organization: IRCCS “Casa Sollievo della Sofferenza”
– sequence: 9
  givenname: Raffaele
  surname: Antonelli Incalzi
  fullname: Antonelli Incalzi, Raffaele
  organization: Università Campus Bio‐Medico di Roma
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38321367$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtPxCAUhYnR6PhY-AcMS11UeRSmXerEV2KiC103lF5GDFMq0Ez8Bf5tGUddmCgbbsh3Tw7n7KLN3veA0CElpzSfs1YPp1QSSjbQhHIpCkaZ2EQTwoksBBN0B-3G-EII5VSKbbTDK84yOJ2g9_NhCH4IViXoIUbsDe5sAJ2wD8ph1ServZqPLk94CBB1sK3t59j22LsOAo5j-5L5iJc2PWOVspbDxrbBOqeS9X0WjPpZhTl02AS_wEqPCfACOqszulShi_toyygX4eDr3kNPV5ePs5vi7v76dnZ-V2jOBCkUF7JcTa0ygmmjGVdVTWvJV08tMbVmVTkFqqtOcl1PSwGiVJWkJTWcVnwPHa91869fR4ipWWRzkJ324MfYsJrxlT6RGT36Qsc2e21ySAsV3prv8DJwsgZ08DEGMD8IJc2qmCYX03wWk9mzX6y26TOdFJR1_20srYO3v6Wbi9nDeuMD5KigOQ
CitedBy_id crossref_primary_10_7759_cureus_74526
crossref_primary_10_1007_s41999_024_01059_x
Cites_doi 10.7326/0003‐4819‐157‐7‐201210020‐00003
10.3389/fcvm.2022.1060096
10.1111/bcp.13631
10.1111/bcp.14029
10.1161/JAHA.119.014108
10.3390/pharmaceutics14071410
10.1007/s40266‐020‐00767‐w
10.3389/fphar.2018.01220
10.1001/archinte.159.7.677
10.1016/j.injury.2015.06.013
10.1111/jgs.15767
10.1080/07853890.2022.2117407
10.1093/europace/euab065
10.1161/CIRCULATIONAHA.110.004747
10.1161/CIRCULATIONAHA.113.005008
10.1016/j.arr.2011.03.003
10.1007/s11845‐018‐1837‐7
10.1093/europace/eux316
10.1016/j.ejim.2019.05.002
10.1186/s12877‐022‐03279‐x
10.3389/fphar.2022.996042
10.1093/ageing/afu145
10.2147/IJGM.S129235
ContentType Journal Article
Copyright 2024 British Pharmacological Society.
Copyright_xml – notice: 2024 British Pharmacological Society.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/bcp.16010
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1365-2125
EndPage 1239
ExternalDocumentID 38321367
10_1111_bcp_16010
BCP16010
Genre article
Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HYE
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
TR2
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3250-a35643250baf52cfc23a89196350bab0f9c2847e1c8d63c9745e54a86141f3183
IEDL.DBID DR2
ISSN 0306-5251
1365-2125
IngestDate Thu Jul 10 16:42:48 EDT 2025
Tue Sep 02 02:08:32 EDT 2025
Tue Jul 01 01:59:34 EDT 2025
Thu Apr 24 23:03:13 EDT 2025
Wed Jan 22 17:19:22 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords direct oral anticoagulants
atrial fibrillation
older
inappropriate medications
drug–drug interactions
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2024 British Pharmacological Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3250-a35643250baf52cfc23a89196350bab0f9c2847e1c8d63c9745e54a86141f3183
Notes The principal investigator for this paper is Prof. Raffaele Antonelli Incalzi and he had direct clinical responsibility for patients.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0220-0500
PMID 38321367
PQID 2923325006
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2923325006
pubmed_primary_38321367
crossref_primary_10_1111_bcp_16010
crossref_citationtrail_10_1111_bcp_16010
wiley_primary_10_1111_bcp_16010_BCP16010
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2024
2024-05-00
20240501
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: May 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle British journal of clinical pharmacology
PublicationTitleAlternate Br J Clin Pharmacol
PublicationYear 2024
References 2015; 46
2018; 9
2019; 2019
2021; 23
2012; 157
2019; 85
2019; 65
2017; 10
2015; 44
2022; 9
2020; 9
2022; 13
2020; 37
2022; 14
2011; 10
2018; 84
2022; 54
2022; 22
2014; 130
1999; 159
2018; 20
2019; 188
2011; 123
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_22_1
e_1_2_10_20_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_12_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_11_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 188
  start-page: 101
  issue: 1
  year: 2019
  end-page: 108
  article-title: Is the prescription right? A review of non‐vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non‐valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non‐vitamin K oral anticoagulants in stroke prevention (SAFE‐NOACS) group
  publication-title: Ir J Med Sci
– volume: 13
  start-page: 13
  year: 2022
  article-title: A focus on CKD reporting and inappropriate prescribing among older patients discharged from geriatric and nephrology units throughout Italy: a nationwide multicenter retrospective cross‐sectional study
  publication-title: Front Pharmacol
– volume: 130
  start-page: 138
  issue: 2
  year: 2014
  end-page: 146
  article-title: Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
  publication-title: Circulation
– volume: 54
  start-page: 2411
  issue: 1
  year: 2022
  end-page: 2419
  article-title: The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF)
  publication-title: Ann Med
– volume: 159
  start-page: 677
  issue: 7
  year: 1999
  end-page: 685
  article-title: Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls
  publication-title: Arch Intern Med
– volume: 85
  start-page: 2134
  issue: 9
  year: 2019
  end-page: 2142
  article-title: Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM‐AF cluster randomized clinical trial
  publication-title: Br J Clin Pharmacol
– volume: 2019
  start-page: 674
  issue: 67
  year: 2019
  end-page: 694
  article-title: Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults
  publication-title: J Am Geriatr Soc
– volume: 10
  start-page: 87
  year: 2017
  end-page: 94
  article-title: Utilization and prescribing patterns of direct oral anticoagulants
  publication-title: Int J Gen Med
– volume: 123
  start-page: 2363
  issue: 21
  year: 2011
  end-page: 2372
  article-title: Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation
  publication-title: Circulation
– volume: 157
  start-page: 471
  issue: 7
  year: 2012
  end-page: 481
  article-title: Two novel equations to estimate kidney function in persons aged 70 years or older
  publication-title: Ann Intern Med
– volume: 46
  start-page: 1765
  issue: 9
  year: 2015
  end-page: 1771
  article-title: Injuries and outcomes associated with traumatic falls in the elderly population on oral anticoagulant therapy
  publication-title: Injury
– volume: 22
  start-page: 601
  issue: 1
  year: 2022
  article-title: Prevalence and factors associated with polypharmacy: a systematic review and meta‐analysis
  publication-title: BMC Geriatr
– volume: 65
  start-page: 51
  year: 2019
  end-page: 57
  article-title: Drug–drug interactions involving CYP3A4 and p‐glycoprotein in hospitalized elderly patients
  publication-title: Eur J Intern Med
– volume: 9
  issue: 6
  year: 2020
  article-title: Rates of potentially inappropriate dosing of direct‐acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE‐AF study
  publication-title: J Am Heart Assoc
– volume: 44
  start-page: 213
  issue: 2
  year: 2015
  end-page: 218
  article-title: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
  publication-title: Age Ageing
– volume: 10
  start-page: 430
  issue: 4
  year: 2011
  end-page: 439
  article-title: Aging with multimorbidity: a systematic review of the literature
  publication-title: Ageing Res Rev
– volume: 14
  start-page: 1410
  issue: 7
  year: 2022
  article-title: Drug–drug interactions with oral anticoagulants as potentially inappropriate medications: prevalence and outcomes in elderly patients in primary care and hospital settings
  publication-title: Pharmaceutics
– volume: 37
  start-page: 585
  issue: 8
  year: 2020
  end-page: 593
  article-title: Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post‐discharge health outcomes?
  publication-title: Drugs Aging
– volume: 9
  year: 2018
  article-title: Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing
  publication-title: Front Pharmacol
– volume: 23
  start-page: 1612
  issue: 10
  year: 2021
  end-page: 1676
  article-title: 2021 European Heart Rhythm Association practical guide on the use of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
  publication-title: EP Europace
– volume: 9
  year: 2022
  article-title: Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 2
  publication-title: Front Cardiovasc Med
– volume: 84
  start-page: 2010
  issue: 9
  year: 2018
  end-page: 2019
  article-title: Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation
  publication-title: Br J Clin Pharmacol
– volume: 20
  start-page: 1577
  issue: 10
  year: 2018
  end-page: 1583
  article-title: Inappropriate doses of direct oral anticoagulants in real‐world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry
  publication-title: EP Europace
– ident: e_1_2_10_15_1
  doi: 10.7326/0003‐4819‐157‐7‐201210020‐00003
– ident: e_1_2_10_26_1
  doi: 10.3389/fcvm.2022.1060096
– ident: e_1_2_10_6_1
  doi: 10.1111/bcp.13631
– ident: e_1_2_10_7_1
  doi: 10.1111/bcp.14029
– ident: e_1_2_10_13_1
  doi: 10.1161/JAHA.119.014108
– ident: e_1_2_10_12_1
  doi: 10.3390/pharmaceutics14071410
– ident: e_1_2_10_4_1
  doi: 10.1007/s40266‐020‐00767‐w
– ident: e_1_2_10_8_1
  doi: 10.3389/fphar.2018.01220
– ident: e_1_2_10_27_1
  doi: 10.1001/archinte.159.7.677
– ident: e_1_2_10_28_1
  doi: 10.1016/j.injury.2015.06.013
– ident: e_1_2_10_21_1
  doi: 10.1111/jgs.15767
– ident: e_1_2_10_23_1
  doi: 10.1080/07853890.2022.2117407
– ident: e_1_2_10_22_1
  doi: 10.1093/europace/euab065
– ident: e_1_2_10_24_1
  doi: 10.1161/CIRCULATIONAHA.110.004747
– ident: e_1_2_10_16_1
– ident: e_1_2_10_19_1
– ident: e_1_2_10_25_1
  doi: 10.1161/CIRCULATIONAHA.113.005008
– ident: e_1_2_10_2_1
  doi: 10.1016/j.arr.2011.03.003
– ident: e_1_2_10_11_1
  doi: 10.1007/s11845‐018‐1837‐7
– ident: e_1_2_10_9_1
  doi: 10.1093/europace/eux316
– ident: e_1_2_10_5_1
  doi: 10.1016/j.ejim.2019.05.002
– ident: e_1_2_10_18_1
– ident: e_1_2_10_3_1
  doi: 10.1186/s12877‐022‐03279‐x
– ident: e_1_2_10_17_1
– ident: e_1_2_10_14_1
  doi: 10.3389/fphar.2022.996042
– ident: e_1_2_10_20_1
  doi: 10.1093/ageing/afu145
– ident: e_1_2_10_10_1
  doi: 10.2147/IJGM.S129235
SSID ssj0013165
Score 2.4378836
Snippet Aims Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical...
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1231
SubjectTerms Administration, Oral
Age Factors
Aged
Aged, 80 and over
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
atrial fibrillation
Atrial Fibrillation - drug therapy
direct oral anticoagulants
Drug Interactions
drug–drug interactions
Factor Xa Inhibitors - administration & dosage
Factor Xa Inhibitors - adverse effects
Factor Xa Inhibitors - therapeutic use
Female
Hospitalization - statistics & numerical data
Humans
inappropriate medications
Inappropriate Prescribing - prevention & control
Inappropriate Prescribing - statistics & numerical data
Italy - epidemiology
Male
older
Patient Discharge
Practice Patterns, Physicians' - standards
Practice Patterns, Physicians' - statistics & numerical data
Title Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcp.16010
https://www.ncbi.nlm.nih.gov/pubmed/38321367
https://www.proquest.com/docview/2923325006
Volume 90
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA7Fkxffj_piFCke3NJ9tVs8qSjFgxRpoQdhSbKJiHVb3N2D_gH_tjNJt7U-QLyFJRt2k3l8SWa-Yew4SjhafVwBGYqWE_hBy-Gi5TlChUlDoFQpZaJ8b5udfnAzCAcVdlbmwlh-iOmBG2mGsdek4Fxkn5RcyDEdjZj0KorVIkB0581uEFxTRpIgMW62QnfCKkRRPNM3533RN4A5j1eNw7leZvflp9o4k6d6kYu6fPvC4vjPf1lhSxMgCudWclZZRaVrrNa1TNavp9CbJWZlp1CD7ozj-nWdvZ8TF_kYpTc3xhJGGqx3BEr5B1wvFDFOde7THCjYFq0TbsIf4DGFEVUGh6wQdAaUAR0FAzflQ0BTBsLQxucBZQwTkZNKgLJggMsiV_Bsr5aAwn2zDda_vupddpxJTQdH-oi2HO6HiIGwJbgOPaml5_OoTWaAHomGbktymMqVUdL0Je52QhUGPEIU4WqyP5tsIR2laptBJIRU6GBF4spAy3Zbc7I_vg40ojDNq-ykXN1YTgjPqe7GMC43PjjtsZn2Kjuadh1blo-fOh2WIhKjDtLFCk_VqMhiD1Ey_VOjWWVbVnamw_hUCspvtvBrjAT8Pn58cdk1jZ2_d91lix6iLBuBuccW8pdC7SNKysWBUYcPGHEPxg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4heiiXAi1tA4VOK4R6wFH8ShyJS0iLQktRhILEpbJ217sVApwI2wf6B_q3mdmNk_KSKm6Wtbbs3Xl8OzszH8B2kgmy-rQCKpYdLwqjjidkJ_CkjrOWJKnS2mb5HrcHp9H3s_hsAfbqWhjXH2IWcGPNsPaaFZwD0v9ouVQTjo1wfdULZvRm_oKvJ8H8DMG3RJIMimm7FfvTvkKcxzN79K43egAx7yJW63IOluFX_bEu0-SiWZWyqf7c6-P43L9ZgVdTLIo9JzyrsKDz17AzdM2sb3ZxNK_NKnZxB4fzNtc3b-Bvj9uRT0iAS2svcWzQOUjkqn-kJSMpE0x1n5fI-bZkoGgf_hvPcxwzOTgWleQwUIEcDUZhGUTQcBHCpUvRQy4a5l5OOkMuhEGhqlLjlTtdQs74Ldbg9ODbqD_wprQOngoJcHkijAkG0ZUUJg6UUUEoki5bAr4lW6ar2GdqXyVZO1S04Yl1HImEgIRv2AS9hcV8nOv3gImUSpOPlZmvIqO6XSPYBIUmMgTEjGjAl3p5UzXtec7UG5dpvfehaU_ttDfg82zoxDX6eGzQp1pGUlJDPlsRuR5XRRoQUOZ_arUb8M4Jz-w1IbNBhe0OfY0Vgaffn-73h_Zi_f-HfoSXg9HPo_To8PjHBiwFBLpcQuYHWCyvK71JoKmUW1Y3bgH3LxPg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bSxwxFD6IQulL1d5cL-1pEfHBWXauO4tPW9vFtiKLKPhQGJJMIqLOLs7Mg_4B_7bnJDu7rm2h9C0MmTCTnMuX5JzvAGynuSCrTyugYtn1ojDqekJ2A0_qOO9IkiqtbZTvcXJ4Fv04j88XYL_JhXH8ENMDN9YMa69Zwce5eaLkUo35aITTq5aihJSFEdFJMLtC8G0dScbEtNuK_QmtEIfxTF-dd0a_Icx5wGo9zmAZfjXf6gJNrtp1Jdvq_hmN43_-zAq8miBR7DvRWYUFXbyGnaGjsr7bw9NZZla5hzs4nJFc372Bhz6TkY9JfCtrLXFk0LlH5Jx_pAUjGRNc6L6okKNtyTzRLvwCLwsccWlwLGvJh0Al8lkwCls_BA2nIFy7AD3klGFmctI5choMClVXGm_c3RJyvG_5Fs4G304PDr1JUQdPhQS3PBHGBIKoJYWJA2VUEIq0x3aAH8mO6Sn2mNpXaZ6EirY7sY4jkRKM8A0boHewWIwKvQaYSqk0eViZ-yoyqtczgg1QaCJDMMyIFuw2q5upCeM5F964zpqdD017Zqe9BZ-nXceO5uNPnT41IpKREvLNiij0qC6zgGAy_1MnacF7JzvTYUKuBRUmXfoaKwF_Hz_7cjC0jfV_7_oRXgy_DrKj78c_N-BlQIjLRWNuwmJ1W-stQkyV_GA14xHS-xKY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Appropriateness+of+direct+oral+anticoagulant+prescribing+in+older+subjects+with+atrial+fibrillation+discharged+from+acute+medical+wards&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=De+Vincentis%2C+Antonio&rft.au=Soraci%2C+Luca&rft.au=Arena%2C+Elena&rft.au=Sciacqua%2C+Angela&rft.date=2024-05-01&rft.eissn=1365-2125&rft.volume=90&rft.issue=5&rft.spage=1231&rft_id=info:doi/10.1111%2Fbcp.16010&rft_id=info%3Apmid%2F38321367&rft.externalDocID=38321367
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon